NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

jm100,

Today, Dr. David W. Andrews, an Imvax co-founder and Chief Medical Officer spoke about " a Phase 2b Study of IGV -001 in Newly Diagnosed Glioblastoma" here;

Plus Therapeutics to present at EBCI's virtual educational event this Friday at 12 pm PT / 3 pm ET.
Register now: https://t.co/Jq67TondMV#btsm #NIH #clinicaltrial #gbm #glioblastoma #neurosurgery #nuclearmedicine #oncology #raredisease #targeted #radiation #therapy https://t.co/IncldMqkdO pic.twitter.com/0PsWbIUXQp

— Plus Therapeutics (Nasdaq: PSTV) (@plustxinc) May 15, 2023

If interested in paticipating in the study you can contact them by e-mail at [e-mail] or using the form found at https://www.imvax.com/patients-families/
I will post the recorded version when available.